TAS4464, a Novel, Highly Potent NEDD8-Activating Enzyme Inhibitor Shows Antitumor Activity in Ibrutinib-Insensitive Mantle Cell Lymphoma Via Inactivation of the NF-κB Pathway

被引：0
|
作者：
Muraoka, Hiromi
Yoshimura, Chihoko
Tsuji, Shingo
Hashimoto, Akihiro
Nakagawa, Fumio
Mizutani, Takashi
Ohkubo, Shuichi
Matsuo, Kenichi
Utsugi, Teruhiro
Iwasawa, Yoshikazu
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4103
引用
收藏
页数：2
相关论文
共 18 条
  • [1] TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models
    Yoshimura, Chihoko
    Muraoka, Hiromi
    Ochiiwa, Hiroaki
    Tsuji, Shingo
    Hashimoto, Akihiro
    Kazuno, Hiromi
    Nakagawa, Fumio
    Komiya, Yu
    Suzuki, Satoshi
    Takenaka, Toru
    Kumazaki, Masafumi
    Fujita, Naoya
    Mizutani, Takashi
    Ohkubo, Shuichi
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (07) : 1205 - 1216
  • [2] TAS4464, a novel highly potent NEDD8 activating enzyme inhibitor, demonstrates antitumor activity in multiple myeloma through the inactivation of NF-κB pathways
    Muraoka, Hiromi
    Yoshimura, Chihoko
    Tsuji, Shingo
    Suzuki, Takamasa
    Hashimoto, Akihiro
    Mizutani, Takashi
    Ohkubo, Shuichi
    Matsuo, Kenichi
    Lwasawa, Yoshikazu
    Utsugi, Teruhiro
    [J]. CANCER RESEARCH, 2015, 75
  • [3] TAS4464, a novel and highly potent NEDD8 activating enzyme (NAE) inhibitor, causes apoptosis of sarcomas via cell cycle dysregulation
    Fujita, Hidenori
    Fujioka, Yayoi
    Ishida, Keiji
    Yoshimura, Chihoko
    Hashimoto, Akihiro
    Tsuji, Shingo
    Mizutani, Takashi
    Okubo, Shuichi
    Matsuo, Kenichi
    Utsugi, Teruhiro
    Iwasawa, Yoshikazu
    [J]. CANCER RESEARCH, 2016, 76
  • [4] Activity of TAS4464, a novel NEDD8 activating enzyme E1 inhibitor, against multiple myeloma via inactivation of nuclear factor κB pathways
    Muraoka, Hiromi
    Yoshimura, Chihoko
    Kawabata, Rumi
    Tsuji, Shingo
    Hashimoto, Akihiro
    Ochiiwa, Hiroaki
    Nakagawa, Fumio
    Fujioka, Yayoi
    Matsuo, Kenichi
    Ohkubo, Shuichi
    [J]. CANCER SCIENCE, 2019, 110 (12) : 3802 - 3810
  • [5] TAS4464, a novel highly potent NEDD8 activating enzyme inhibitor, demonstrates anti-tumor efficacy in rituximab-resistant double-hit lymphoma models
    Muraoka, H.
    Yoshimura, C.
    Tsuji, S.
    Hashimoto, A.
    Mizutani, T.
    Ohkubo, S.
    Matsuo, K.
    Utsugi, T.
    Iwasawa, Y.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 69 : S152 - S152
  • [6] TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemia
    Hiroaki Ochiiwa
    Guzhanuer Ailiken
    Masataka Yokoyama
    Kazuyuki Yamagata
    Hidekazu Nagano
    Chihoko Yoshimura
    Hiromi Muraoka
    Keiji Ishida
    Tomonori Haruma
    Akitoshi Nakayama
    Naoko Hashimoto
    Kazutaka Murata
    Motoi Nishimura
    Yusuke Kawashima
    Osamu Ohara
    Shuichi Ohkubo
    Tomoaki Tanaka
    [J]. Oncogene, 2021, 40 : 1217 - 1230
  • [7] TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemia
    Ochiiwa, Hiroaki
    Ailiken, Guzhanuer
    Yokoyama, Masataka
    Yamagata, Kazuyuki
    Nagano, Hidekazu
    Yoshimura, Chihoko
    Muraoka, Hiromi
    Ishida, Keiji
    Haruma, Tomonori
    Nakayama, Akitoshi
    Hashimoto, Naoko
    Murata, Kazutaka
    Nishimura, Motoi
    Kawashima, Yusuke
    Ohara, Osamu
    Ohkubo, Shuichi
    Tanaka, Tomoaki
    [J]. ONCOGENE, 2021, 40 (07) : 1217 - 1230
  • [8] Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo
    Czuczman, Natalie M.
    Barth, Matthew J.
    Gu, Juan
    Neppalli, Vishala
    Mavis, Cory
    Frys, Sarah E.
    Hu, Qiang
    Liu, Song
    Klener, Pavel
    Vockova, Petra
    Czuczman, Myron S.
    Hernandez-Ilizaliturri, Francisco J.
    [J]. BLOOD, 2016, 127 (09) : 1128 - 1137
  • [9] Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
    Torka, Pallawi
    Kambhampati, Swetha
    Chen, Lu
    Wang, Xiaoguang
    Chen, Canping
    Vuong, Dan
    Qin, Hanjun
    Muir, Alexandra
    Orand, Kirsten
    Borja, Ivana
    Lynne Smith, D.
    Herrera, Alex F.
    Spurgeon, Stephen E. F.
    Park, Byung
    Lewis, Lionel D.
    Hernandez-Ilizaliturri, Francisco
    Xia, Zheng
    Danilov, Alexey V.
    [J]. BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [10] MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB-dependent lymphoma
    Milhollen, Michael A.
    Traore, Tary
    Adams-Duffy, Jennifer
    Thomas, Michael P.
    Berger, Allison J.
    Dang, Lenny
    Dick, Lawrence R.
    Garnsey, James J.
    Koenig, Erik
    Langston, Steven P.
    Manfredi, Mark
    Narayanan, Usha
    Rolfe, Mark
    Staudt, Louis M.
    Soucy, Teresa A.
    Yu, Jie
    Zhang, Julie
    Bolen, Joseph B.
    Smith, Peter G.
    [J]. BLOOD, 2010, 116 (09) : 1515 - 1523
12